Copyright Reports & Markets. All rights reserved.

Global Personal Genome Testing Market Size, Status and Forecast 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Personal Genome Testing Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Targeted Testing
      • 1.4.3 Non-Targeted Testing
      • 1.4.4 Multi-Targeted Testing
    • 1.5 Market by Application
      • 1.5.1 Global Personal Genome Testing Market Share by Application (2014-2025)
      • 1.5.2 Neurological Disorders
      • 1.5.3 Oncology
      • 1.5.4 Metabolic Disorders
      • 1.5.5 Autoimmune Disorders
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Personal Genome Testing Market Size
    • 2.2 Personal Genome Testing Growth Trends by Regions
      • 2.2.1 Personal Genome Testing Market Size by Regions (2014-2025)
      • 2.2.2 Personal Genome Testing Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Personal Genome Testing Market Size by Manufacturers
      • 3.1.1 Global Personal Genome Testing Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Personal Genome Testing Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Personal Genome Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2 Personal Genome Testing Key Players Head office and Area Served
    • 3.3 Key Players Personal Genome Testing Product/Solution/Service
    • 3.4 Date of Enter into Personal Genome Testing Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Personal Genome Testing Market Size by Type (2014-2019)
    • 4.2 Global Personal Genome Testing Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Personal Genome Testing Market Size (2014-2019)
    • 5.2 Personal Genome Testing Key Players in United States
    • 5.3 United States Personal Genome Testing Market Size by Type
    • 5.4 United States Personal Genome Testing Market Size by Application

    6 Europe

    • 6.1 Europe Personal Genome Testing Market Size (2014-2019)
    • 6.2 Personal Genome Testing Key Players in Europe
    • 6.3 Europe Personal Genome Testing Market Size by Type
    • 6.4 Europe Personal Genome Testing Market Size by Application

    7 China

    • 7.1 China Personal Genome Testing Market Size (2014-2019)
    • 7.2 Personal Genome Testing Key Players in China
    • 7.3 China Personal Genome Testing Market Size by Type
    • 7.4 China Personal Genome Testing Market Size by Application

    8 Japan

    • 8.1 Japan Personal Genome Testing Market Size (2014-2019)
    • 8.2 Personal Genome Testing Key Players in Japan
    • 8.3 Japan Personal Genome Testing Market Size by Type
    • 8.4 Japan Personal Genome Testing Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Personal Genome Testing Market Size (2014-2019)
    • 9.2 Personal Genome Testing Key Players in Southeast Asia
    • 9.3 Southeast Asia Personal Genome Testing Market Size by Type
    • 9.4 Southeast Asia Personal Genome Testing Market Size by Application

    10 India

    • 10.1 India Personal Genome Testing Market Size (2014-2019)
    • 10.2 Personal Genome Testing Key Players in India
    • 10.3 India Personal Genome Testing Market Size by Type
    • 10.4 India Personal Genome Testing Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Personal Genome Testing Market Size (2014-2019)
    • 11.2 Personal Genome Testing Key Players in Central & South America
    • 11.3 Central & South America Personal Genome Testing Market Size by Type
    • 11.4 Central & South America Personal Genome Testing Market Size by Application

    12 International Players Profiles

    • 12.1 23andMe, Inc.
      • 12.1.1 23andMe, Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Personal Genome Testing Introduction
      • 12.1.4 23andMe, Inc. Revenue in Personal Genome Testing Business (2014-2019)
      • 12.1.5 23andMe, Inc. Recent Development
    • 12.2 Navigenics
      • 12.2.1 Navigenics Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Personal Genome Testing Introduction
      • 12.2.4 Navigenics Revenue in Personal Genome Testing Business (2014-2019)
      • 12.2.5 Navigenics Recent Development
    • 12.3 deCODEme
      • 12.3.1 deCODEme Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Personal Genome Testing Introduction
      • 12.3.4 deCODEme Revenue in Personal Genome Testing Business (2014-2019)
      • 12.3.5 deCODEme Recent Development
    • 12.4 Color Genomics, Inc.
      • 12.4.1 Color Genomics, Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Personal Genome Testing Introduction
      • 12.4.4 Color Genomics, Inc. Revenue in Personal Genome Testing Business (2014-2019)
      • 12.4.5 Color Genomics, Inc. Recent Development
    • 12.5 Personal Genome Diagnostics, Inc.
      • 12.5.1 Personal Genome Diagnostics, Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Personal Genome Testing Introduction
      • 12.5.4 Personal Genome Diagnostics, Inc. Revenue in Personal Genome Testing Business (2014-2019)
      • 12.5.5 Personal Genome Diagnostics, Inc. Recent Development
    • 12.6 Counsyl, Inc.
      • 12.6.1 Counsyl, Inc. Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Personal Genome Testing Introduction
      • 12.6.4 Counsyl, Inc. Revenue in Personal Genome Testing Business (2014-2019)
      • 12.6.5 Counsyl, Inc. Recent Development
    • 12.7 Quest Diagnostics
      • 12.7.1 Quest Diagnostics Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Personal Genome Testing Introduction
      • 12.7.4 Quest Diagnostics Revenue in Personal Genome Testing Business (2014-2019)
      • 12.7.5 Quest Diagnostics Recent Development
    • 12.8 Gene By Gene, Ltd.
      • 12.8.1 Gene By Gene, Ltd. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Personal Genome Testing Introduction
      • 12.8.4 Gene By Gene, Ltd. Revenue in Personal Genome Testing Business (2014-2019)
      • 12.8.5 Gene By Gene, Ltd. Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Personal Genome Testing market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Personal Genome Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Personal Genome Testing development in United States, Europe and China.

      The key players covered in this study
      23andMe, Inc.
      Navigenics
      deCODEme
      Color Genomics, Inc.
      Personal Genome Diagnostics, Inc.
      Counsyl, Inc.
      Quest Diagnostics
      Gene By Gene, Ltd.

      Market segment by Type, the product can be split into
      Targeted Testing
      Non-Targeted Testing
      Multi-Targeted Testing

      Market segment by Application, split into
      Neurological Disorders
      Oncology
      Metabolic Disorders
      Autoimmune Disorders
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Personal Genome Testing status, future forecast, growth opportunity, key market and key players.
      To present the Personal Genome Testing development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Personal Genome Testing are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now